β-Lactamases identified in clinical isolates ofPseudomonas aeruginosa

Three Decades of  -Lactamase Inhibitors

(2010) S. M. Drawz et al.   CLINICAL MICROBIOLOGY REVIEWS

Further Identification of CTX-M-2 Extended-Spectrum  -Lactamase in Pseudomonas aeruginosa

(2009) R. C. Picao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa

(2009) J.-M. Rodriguez-Martinez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First Organisms with Acquired Metallo- -Lactamases (IMP-13, IMP-22, and VIM-2) Reported in Austria

(2009) W. Duljasz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Epidemiology of Outbreak-Related Pseudomonas aeruginosa Strains Carrying the Novel Variant blaVIM-17 Metallo- -Lactamase Gene

(2009) V. I. Siarkou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Detection of the Novel Extended-Spectrum  -Lactamase OXA-161 from a Plasmid-Located Integron in Pseudomonas aeruginosa Clinical Isolates from Spain

(2009) C. Juan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Diversity, Epidemiology, and Genetics of Class D  -Lactamases

(2009) L. Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Updated Functional Classification of  -Lactamases

(2009) K. Bush et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

AmpC  -Lactamases

(2009) G. A. Jacoby   CLINICAL MICROBIOLOGY REVIEWS

Beta-lactams and Beta-lactamase-inhibitors in current- or potential-clinical practice: A comprehensive update

(2009) M. Shahid et al.   CRITICAL REVIEWS IN MICROBIOLOGY

Current Status of Newer Carbapenems

(2009) Matteo Bassetti et al.   CURRENT MEDICINAL CHEMISTRY

Relevance of resistance levels to carbapenems and integron-borne blaIMP-1, blaIMP-7, blaIMP-10 and blaVIM-2 in clinical isolates of Pseudomonas aeruginosa

(2009) W.-H. Zhao et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Identification of plasmid- and integron-borne blaIMP-1 and blaIMP-10 in clinical isolates of Serratia marcescens

(2009) Z. Hu et al.   JOURNAL OF MEDICAL MICROBIOLOGY

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

(2009) Patrice Nordmann et al.   LANCET INFECTIOUS DISEASES

VIM-15 and VIM-16, Two New VIM-2-Like Metallo- -Lactamases in Pseudomonas aeruginosa Isolates from Bulgaria and Germany

(2008) I. Schneider et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Metallo- -Lactamase Gene blaIMP-15 in a Class 1 Integron, In95, from Pseudomonas aeruginosa Clinical Isolates from a Hospital in Mexico

(2008) U. Garza-Ramos et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Phenotypic and Enzymatic Comparative Analysis of the Novel KPC Variant KPC-5 and Its Evolutionary Variants, KPC-2 and KPC-4

(2008) D. J. Wolter et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterization of the New Metallo- -Lactamase VIM-13 and Its Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in Spain

(2008) C. Juan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First Countrywide Survey of Acquired Metallo- -Lactamases in Gram-Negative Pathogens in Italy

(2008) G. M. Rossolini et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenem Resistance among Pseudomonas aeruginosa Strains from India: Evidence for Nationwide Endemicity of Multiple Metallo- -Lactamase Clones (VIM-2, -5, -6, and -11 and the Newly Characterized VIM-18)

(2008) M. Castanheira et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efflux Mechanism, an Attractive Target to Combat Multidrug Resistant Plasmodium falciparum and Pseudomonas aeruginosa

(2008) Sandrine Alibert-Franco et al.   CURRENT MEDICINAL CHEMISTRY

Outbreak by meropenem-resistant Pseudomonas aeruginosa producing IMP-6 metallo-β-lactamase in a Korean hospital

(2008) Nam Hee Ryoo et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum  -lactamases in the United Kingdom

(2008) N. Woodford et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY